
Moody's Ratings reduces China's 2025 growth forecast to 3.8% from 4.5%
In February, the rating agency had projected a GDP growth of 4.5 per cent and 4 per cent respectively for 2025 and 2026. The new projection also falls well short of the Chinese government's official 5 per cent growth target.
However, the country's GDP rose by 5.4 per cent year-on-year in the first quarter of 2025, indicating a strong start for the financial year.
China may see a major slowdown in two years, with growth falling to 3.8 per cent in 2025 and 3.9 per cent in 2026 as trade tensions escalate and global economic conditions weigh on investment and consumer confidence, Moody's Ratings said. In February, it projected a GDP growth of 4.5 per cent for 2025 and 4 per cent for 2026. US tariffs on China will be 'considerably restrictive' in the near term.
This early-year boost was largely driven by a surge in exports and a combination of government fiscal and monetary policies aimed towards stabilising growth. Fixed asset investment improved, property sector contraction eased, and credit demand levelled off while industrial production and retail sales also showed signs of recovery, a report by the rating agency said.
However, it cautioned that without further stimulus beyond measures announced at the annual Two Sessions in March, the current momentum may not stay the same for long.
A heavy drop in Chinese shipments to the United States in April, combined with the growing impact of elevated tariffs, is casting a long shadow over the outlook for the coming months.
Moody's Ratings believes US tariffs on Chinese products will remain 'considerably restrictive' in the near term.
The rating agency said domestic demand remains vulnerable despite Beijing's continued investment in high-tech and green industries. Even support from government's fiscal and monetary policies is 'unlikely to lift domestic demand enough to offset the negative impact on external demand'.
The trade measures imposed by the China and United States on each other are 'so prohibitively high that they would likely choke off most direct bilateral trade if they remain in place, on top of the likely short-term disruptions noted earlier,' the report noted.
Fibre2Fashion News Desk (DS)

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
7 minutes ago
- Time of India
Nvidia says its chips have no 'backdoors' after China flags H20 security concerns
Academy Empower your mind, elevate your skills Nvidia said on Thursday its products have no "backdoors" that would allow remote access or control after China raised concerns over potential security risks in the firm's H20 artificial intelligence Cyberspace Administration of China, the country's internet regulator, said it was concerned by a US proposal for advanced chips sold abroad to be equipped with tracking and positioning functions. The CAC's move cast uncertainty over the US company's sales prospects in China weeks after a US export ban was regulator said it had summoned Nvidia to a meeting on Thursday to explain whether its H20 AI chip had any backdoor security risks , as it was worried that Chinese user data and privacy rights could be affected. A backdoor risk refers to a hidden method of bypassing normal authentication or security a statement, an Nvidia spokesperson said, "Cybersecurity is critically important to us. Nvidia does not have 'backdoors' in our chips that would give anyone a remote way to access or control them." The White House and both houses of US Congress have proposed the idea of requiring U.S. chip firms to include location verification technology with their chips to prevent them from being diverted to countries where U.S. export laws ban sales. The separate bills and White House recommendation have not become a formal rule, and no technical requirements have been has been a focus of US-China relations, and China's move comes shortly after the US this month reversed an April ban on Nvidia selling the H20 chip to China. The company developed the H20 chip for the Chinese market after the US imposed export restrictions on advanced AI chips in late 2023. Nvidia chips are now dispensable for China. They can be easily put on the negotiating table," said Tilly Zhang, an analyst with Gavekal Dragonomics."China obviously has more courage and domestic substitution capabilities compared to previous years to not rely on overseas technology." This month, Nvidia CEO Jensen Huang embarked on a public and effusive visit to China, where he sought to demonstrate his commitment to the Chinese market, met with government officials, and praised the country's AI CAC statement did not elaborate on what backdoor security risks there could be or say what the Chinese government was considering doing as a Chai, an analyst with tech- and consumer-focused 86Research, said Beijing's warning was likely a symbolic stance against similar objections made by US authorities."However, we do not believe Beijing will make excessively harsh demands or introduce regulatory hurdles that will effectively drive Nvidia out of China, for the lack of alternatives. China still needs Nvidia chips for domestic research and applications," Chai products are highly sought after not just by Chinese tech companies but also by Chinese military bodies, state-run AI research institutes, and universities. The company last week placed an order with contract manufacturer TSMC for 300,000 H20 chipsets due to strong demand, Reuters authorities and industry associations have in the past accused U.S. tech companies of posing security risks, with varying early 2023, China barred key operators of the country's infrastructure from purchasing from Micron, saying that a review it conducted had found the U.S. memory chipmaker's products posed serious security year, the Cybersecurity Association of China, an industry group, called for Intel products sold in China to be subject to a security review, but Chinese regulators have not publicly responded. Nvidia is also facing an antitrust investigation in China. The State Administration for Market Regulation announced late last year it was investigating the chipmaker over suspected violations of the country's anti-monopoly regulator said Nvidia was also suspected of violating commitments it made during its acquisition of Israeli chip designer Mellanox Technologies, under terms outlined in the regulator's 2020 conditional approval of that deal.


Time of India
14 minutes ago
- Time of India
Qualcomm shares slide as Apple modem shift, tariffs raise growth concerns
Qualcomm shares fell nearly 5% before the bell on Thursday as the looming loss of Apple as its biggest modem customer outweighed its upbeat quarterly forecast. The San Diego-based chip supplier warned investors that Apple's move to depend on in-house modems, starting with the February launch of the iPhone 16e , would hit future chip revenue. Qualcomm has intensified its focus on sectors such as data centers and personal computers. Adding to the pressure, U.S. President Donald Trump's renewed tariff threats on semiconductors have emerged as a risk, potentially disrupting supply chains and hurting Qualcomm's handset revenue, analysts said. While smartphones and semiconductor chips have so far been exempt from these levies, Trump recently warned he would "soon announce tariffs on semiconductors," raising concerns of sector-specific duties. CFO Akash Palkhiwala told Reuters that the company hasn't seen early chip orders yet, suggesting customers aren't rushing to beat possible tariffs. "Tariffs could trim mid-single digits off handset revenue, but Chinese OEMs (original equipment manufacturers) still view (Qualcomm's mobile phone chip) Snapdragon as essential for global 5G and AI-on-device marketing," said Michael Ashley Schulman, CIO at Running Point Capital. Qualcomm, the world's largest supplier of modem chips and seen as a bellwether for smartphones, said chip sales to non-Apple customers have risen more than 15% this fiscal year, driven by premium Android launches. "We see durable share at Samsung and an extended collaboration with Xiaomi as key support in the handset segment as Apple chipset revenue comes out of the model," TD Cowen analysts said. Qualcomm is also expanding in augmented reality. CEO Cristiano Amon said the company now supports 19 augmented reality designs including META's Ray-Ban smart glasses and expects that number to grow. The company's 12-month forward price-to-earnings ratio is 13.36, trailing Nvidia's 34.91, Intel's 47.14 and Advanced Micro Devices 35.33, according to data compiled by LSEG.


United News of India
19 minutes ago
- United News of India
Indian medical devices exports to US hinges on Trump's tariff on China: Rajiv Nath, AiMeD
Chennai, July 31 (UNI) Indian exports of medical devices can increase to the US if the American import duties on Indian goods are 15-20% lower as compared to the duties levied on Chinese products, said Rajiv Nath, Forum Coordinator, Association of Indian Medical Device Industry (AiMeD). Nath also said the medical devices should also find it feasible to absorb the FDA approval costs and deeming these export costs sustainable. He also said it is premature to comment on US-India tariffs until official announcement. 'US buyers are looking to diversify their supply chains away from China, and India represents a viable alternative, assuming it can ensure quality, competitive pricing, and agility, while also adhering to environmental, social, and corporate responsibility standards,' Nath added. On the lower US import duties on some Asian nations, Nath cautioned that India could face a loss of competitiveness to Indonesia and Vietnam especially in rubber-based products due to their advantageous 19% tariffs within China+1 procurement sourcing options to US buyers. India has to enhance its competitiveness in areas beyond pricing. According to him, greater clarity would be achieved after August 12, upon confirmation of duties on Chinese goods. He noted that these duties, which had previously been increased to over 50% before a temporary reduction to 30%, would provide a benchmark. 'Should duties on Chinese medical devices return to levels exceeding 50% post-August, and should duties on Indian devices by USA are established at 25%, export prospects to the US would likely remain favorable in comparison to China,' Nath said. The ultimate impact of duties on the Indian medical device sector is dependent on relative competitiveness. A duty differential of 15-20% between Chinese and Indian products would favor Indian exports to the USA, potentially incentivizing the establishment of production lines within the US. According to him, Indonesia and Vietnam currently benefit from 6% lower duties at 19% affording them a price advantage, and that the Indian government and manufacturers must work to improve competitiveness to mitigate this 6% disadvantage relative to their Indonesian and Vietnamese counterparts. India's exports of medical devices to USA were Rs. 5,667 crore in 2024 up by 2% from preceding year. Imports from USA were Rs.12,552 crore up by 11% from preceding year. USA is the dominant supplier to India of medical devices with the highest market share of 18 % followed closely by China at 16%, Nath remarked. According to him, the top five exports to USA are: Endoscopes, Orthopedic implants, MRI equipment, Urinary Catheters & Electrocardiographs. The top five Imports from USA are: MRI machine, Orthopaedic Joint implants, IVD Analysers, X Ray Equipment and Cardiac Catheters. UNI VJ RN